Heath Lukatch

Acrigen Biosciences is dedicated to making gene editing safe.

Raised $1,225,000.00 from National Science Foundation and National Science Foundation.

Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.

Raised $25,000,000.00 from Red Tree Venture Capital and Jazz Venture Partners.

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Raised $3,847,040,000.00 from CARB-X and CARB-X.

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Raised $171,000,000.00 from Ally Bridge Group, Red Tree Venture Capital, The Rise Fund, Longitude Capital, RA Capital Management and Redmile Group.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Raised $313,000,000.00 from F-Prime Capital, Janus Henderson Investors, PremjiInvest, Piper Heartland Healthcare Capital, Bioqube Ventures, Omega Funds, The Rise Fund, Braidwell, RA Capital Management and Eight Roads Ventures.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Raised $310,000,000.00 from Woodline Partners, Ally Bridge Group, Saturn V Capital, Novo Holdings, Perceptive Advisors, T. Rowe Price, Wellington Management, Third Rock Ventures, Opaleye Management and Samsara BioCapital.